ConferenceCancer Research · October 1, 2014
AbstractGemcitabine (2′,2′-difluorodeoxycytidine) (dFdC) is a chemotherapeutic drug indicated for the treatment of pancreatic, bladder, NSCLC, breast and ovarian cancers. The use of gemcitabine for the treat ...
Full textCite
ConferenceCancer Research · October 1, 2014
AbstractIntratumoral (i.t.) drug delivery can circumvent the transport barriers_high intratumoral fluid pressure and irregular vascularization_of solid tumors that limit the effectiveness of systemically del ...
Full textCite
ConferenceACS Symposium Series · January 1, 2014
Proteins are heteropolymers of one or more amino acid residues arranged in a molecularly defined fashion. The precise control of amino acid sequence in protein biosynthesis programs the folding of these heteropolymers into diverse three-dimensional structu ...
Full textCite
ConferenceCancer Research · April 15, 2013
AbstractBrachytherapy continues to be one of the predominant radiotherapy modalities for the treatment of prostate cancer. Depending on the stage of the cancer, it is employed either as a stand-alone treatme ...
Full textCite
ConferenceCancer Research · April 15, 2013
AbstractTriple negative breast cancer (TNBC) represents an important clinical challenge, because TNBC, like other breast cancer subtypes is highly metastatic, but TNBC displays a shorter median time to relap ...
Full textCite
ConferenceCancer Research · April 15, 2013
AbstractBrachytherapy seeds are made by sealing radionuclides in metal or other non-degradable material (resin or glass) and surgically implanted into the tumor tissue. Brachytherapy has shown some efficacy ...
Full textCite
ConferenceOptics Infobase Conference Papers · January 1, 2009
I will describe two interfaces for optical biosensors: (1) a label-free biosensor that exploits the local surface plasmon resonance of noble metal nanostructures; and (2) a polymer brush interface on glass that abolishes non-specific adsorption leading to ...
Full textCite